Carbohydrate-Based Tumor Antigens as Antitumor Vaccine Agents

Anticancer Agents - ACS Symposium Series ◽

10.1021/bk-2001-0796.ch018 ◽

2001 ◽

pp. 299-316 ◽

Cited By ~ 2

Author(s):

Jennifer R. Allen ◽

Samuel J. Danishefsky

Keyword(s):

Tumor Antigens ◽

Antitumor Vaccine

Download Full-text

ChemInform Abstract: Carbohydrate-Based Tumor Antigens as Antitumor Vaccine Agents.

ChemInform ◽

10.1002/chin.200224291 ◽

2010 ◽

Vol 33 (24) ◽

pp. no-no

Author(s):

Jennifer R. Allen ◽

Samuel J. Danishefsky

Keyword(s):

Tumor Antigens ◽

Antitumor Vaccine

Download Full-text

Faculty Opinions recommendation of High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1021391.280666 ◽

2005 ◽

Author(s):

Torben Lund

Keyword(s):

T Cells ◽

High Frequency ◽

Tumor Antigens ◽

Before And After ◽

Melanoma Patients

Download Full-text

Faculty Opinions recommendation of Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1092410.546844 ◽

2007 ◽

Author(s):

Pedro Romero

Keyword(s):

Antitumor Immunity ◽

Tumor Antigens ◽

Genetically Modified

Download Full-text

Faculty Opinions recommendation of WDFY4 is required for cross-presentation in response to viral and tumor antigens.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734380628.793560435 ◽

2019 ◽

Author(s):

Malini Raghavan ◽

Jie Geng

Keyword(s):

Tumor Antigens ◽

Cross Presentation

Download Full-text

Faculty Opinions recommendation of Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.738175507.793576641 ◽

2020 ◽

Author(s):

Xiaoming He

Keyword(s):

Cell Membrane ◽

Tumor Antigens ◽

Coated Nanoparticles ◽

Anticancer Immunity

Download Full-text

The Advantages of Multi-Epitope Tumor Antigens as an Approach to Treating Breast Cancer

10.21236/ada384035 ◽

2000 ◽

Author(s):

Sylvia Kiertscher

Keyword(s):

Breast Cancer ◽

Tumor Antigens

Download Full-text

Selection of Human Antibody Fragments which Bind Novel Breast Tumor Antigens

10.21236/ada382534 ◽

1999 ◽

Author(s):

James D. Marks

Keyword(s):

Breast Tumor ◽

Tumor Antigens ◽

Antibody Fragments ◽

Human Antibody ◽

Selection Of

Download Full-text

Strategic Manipulation of Tumor Antigens to Enhance Immunogenicity

10.21236/ada403419 ◽

2001 ◽

Author(s):

Allan D. Hess

Keyword(s):

Tumor Antigens ◽

Strategic Manipulation

Download Full-text

The Advantages of Multi-Epitope Tumor Antigens as an Approach to Treating Breast Cancer

10.21236/ada407499 ◽

2002 ◽

Author(s):

Syvia M. Kiertscher

Keyword(s):

Breast Cancer ◽

Tumor Antigens

Download Full-text

Clinical Trials Targeting Advanced Cancers by Active Immunization of T-cell Defined Tumor Antigens

Current Pharmaceutical Design ◽

10.2174/1381612033454973 ◽

2003 ◽

Vol 9 (14) ◽

pp. 1133-1138 ◽

Cited By ~ 1

Author(s):

Hideyuki Ikeda

Keyword(s):

Clinical Trials ◽

T Cell ◽

Tumor Antigens ◽

Active Immunization

Download Full-text